RTW INVESTMENTS, LP - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q2 2022$3,337,000
-14.5%
490,0000.0%0.09%
+6.2%
Q1 2022$3,905,000
+42.3%
490,0000.0%0.08%
+102.5%
Q4 2021$2,744,000
-27.2%
490,0000.0%0.04%
-29.8%
Q3 2021$3,768,000490,0000.06%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,383,029$24,594,6214.83%
Velan Capital Investment Management LP 494,136$3,592,3693.06%
BVF INC/IL 10,563,748$76,798,4482.81%
JOHNSON & JOHNSON 1,000,000$7,270,0002.36%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,925,7071.16%
PFM Health Sciences, LP 3,204,790$23,298,8231.03%
Pier Capital, LLC 862,736$6,272,0910.95%
Boxer Capital, LLC 2,500,000$18,1750.89%
Deep Track Capital, LP 2,345,073$17,048,6810.70%
SILVERARC CAPITAL MANAGEMENT, LLC 198,477$1,442,9280.60%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders